Iowa State University, BS

​

Eric works on in vitro and in vivo assays related to CAR T cell and bone marrow transplant research as well as the lab's bioinformatics for -omics analysis.

Addis Ababa University, Ethiopia, MSc & DVM

Hannover Medical School, Germany, PhD

​

Dejene's work focuses on understanding the biology, in vitro differentiation, and clinical application of innate lymphoid cells. 

Purdue University, PhD

​

Joselyn studies how efferocytosis, the clearance of apoptotic cells by macrophages, mediates immune evasion and chemoresistance in leukemia and sarcomas. She also works to improve homing and activity of CAR T cells in sarcomas.

Akita University, Japan, MD

Keio University, Japan, PhD

​

Haruko's project seeks to understand the mechanisms of tumor cell resistance to CAR T cells and the biology underlying CAR T cell cytotoxicity. 

Trinity College Dublin

University College Dublin

​

Elena works on NK/ILC development and immunometabolic dysfunction in Down Syndrome. 

Washington University, St. Louis, BA

University of Colorado Health Sciences Center, PhD

​

Kristin works on CAR T cell design and cloning as well as most of the lab's in vitro molecular biological and biochemical assays and in vivo animal studies. 

University of Colorado, Boulder, BA

​

Ben assists with multiple projects in the lab involving both in vitro and in vivo work that primarily focuses on optimizing CAR T cell therapies in solid tumor and bloodborne models. 

University of Nebraska Kearney, BS

University of Nebraska Medical Center, PhD

​

Dallas is an immunologist studying dysfunction in people with Down Syndrome (DS). He investigates novel therapies for DS leukemia; along with interrogating complications in lymph node development that contribute to upper respiratory infections. 

Saint Louis University, BS

​

Patrick's research investigates the efficacy of novel CAR T cells targeting breast cancer.

University of Virginia, BS

PhD Student, Pharmacology

​

Spencer's research investigates novel costimulatory domains to enhance the performance of CAR T cells.